$SOPH 3 SEC Filings

Filed On	Filing
18 Mar 2026	Form 3: Berkovitz Tomer, Director No securities owned
18 Mar 2026	Form 3: Hibbs Kathy L, Director Holds 97,276 shares of Ordinary Shares
18 Mar 2026	Form 3: Cossery Jean-Michel, Director Holds 186,488 shares of Ordinary Shares
18 Mar 2026	Form 3: Puylaert Kevin, Chief Sales Officer Holds 92,419 shares of Ordinary Shares
18 Mar 2026	Form 3: Van Well Daan, Chief Legal Officer Holds 261,922 shares of Ordinary Shares
18 Mar 2026	Form 3: Hirsch Didier, Director Holds 220,496 shares of Ordinary Shares
18 Mar 2026	Form 3: Ossipow Vincent, Director Holds 503,136 shares of Ordinary Shares
18 Mar 2026	Form 3: Camblong Jurgi, Director Holds 3,307,325 shares of Ordinary Shares
18 Mar 2026	Form 3: Xu Zhenyu, Chief Scientific Officer Holds 537,724 shares of Ordinary Shares
18 Mar 2026	Form 3: Verma Abhimanyu, Chief Technology Officer Holds 125,813 shares of Ordinary Shares
18 Mar 2026	Form 3: Cardoza George, Chief Financial Officer Holds 185,632 shares of Ordinary Shares
18 Mar 2026	Form 3: Menu Philippe, Chief Medical Officer Holds 174,224 shares of Ordinary Shares
18 Mar 2026	Form 3: Muken Ross, President Holds 200,000 shares of Ordinary Shares
18 Mar 2026	Form 3: Valente Manuela, Chief People Officer Holds 152,759 shares of Ordinary Shares
18 Mar 2026	Form 3: Cox Troy, Director Holds 309,019 shares of Ordinary Shares

Comments